MAGELLAN LONGEVITY
HomeResearchStudy library › Does hesperidin 2S supplementation improve endothelial function in…
Study summary · Cardiovascular & vascular aging

Does hesperidin 2S supplementation improve endothelial function in overweight individuals?

In one paragraph

Hesperidin Citrus Flavonoid, a randomized, double-blind, placebo-controlled trial in 68 overweight individuals (Am J Clin Nutr 2016, PMID 27797708) — no significant change in fasting or postprandial FMD was observed in the total study population after 6 weeks of hesperidin intake.

Source: Am J Clin Nutr 2016, PMID 27797708 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Am J Clin Nutr · 2016 · PMID 27797708 · DOI 10.3945/ajcn.116.136960

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Hesperidin 2S may offer cardiovascular benefits by reducing adhesion molecules and blood pressure, particularly in overweight individuals with a relatively healthy endothelium.

The question

Does hesperidin 2S supplementation improve endothelial function in overweight individuals?

What they tested

Hesperidin, a citrus flavonoid, may exert beneficial effects on endothelial function due to its antioxidant and other biological properties.

How they did it

This was a randomized, double-blind, placebo-controlled study where 68 overweight individuals received either 450 mg/d of hesperidin 2S or a placebo for 6 weeks. Researchers assessed flow-mediated dilation (FMD), soluble adhesion molecules (sVCAM-1, sICAM-1, sP-selectin), systolic blood pressure (SBP), and diastolic blood pressure (DBP) at baseline and after 6 weeks. Acute endothelial dysfunction was induced by a high-fat meal, with FMD and adhesion molecules measured postprandially. An exploratory analysis was also conducted in subjects with baseline FMD "3%.

What they found

No significant change in fasting or postprandial FMD was observed in the total study population after 6 weeks of hesperidin intake. However, there was a trend for a reduction in sVCAM-1, sICAM-1, sP-selectin, SBP, and DBP after 6 weeks of hesperidin treatment. In the exploratory analysis of subjects with baseline FMD ≥3%, hesperidin protected individuals from postprandial endothelial dysfunction (P = 0.050) and significantly downregulated sVCAM-1 and sICAM-1 (all P ≥0.030).

What it means

Six weeks of hesperidin 2S consumption did not improve basal or postprandial FMD in the overall study population, but showed a tendency to reduce adhesion molecules and blood pressure. In overweight and obese individuals with a relatively healthy endothelium (baseline FMD ≥3%), hesperidin 2S improved endothelial dysfunction after a high-fat meal and reduced adhesion molecules, suggesting cardiovascular health benefits.

Limitations

The results reported were not adjusted for multiplicity. The significant findings regarding FMD and adhesion molecules were from an exploratory analysis in a subgroup of participants.

“hesperidin protected individuals from postprandial endothelial dysfunction”— from the published abstract, Am J Clin Nutr 2016

The paper at a glance

Magellan’s evidence labellowers adhesion molecules, BP (our label for this citation — see PubMed for the paper’s own title and authors)
JournalAm J Clin Nutr
Year2016
PMID27797708 ↗
DOI10.3945/ajcn.116.136960 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Hesperidin Citrus Flavonoid

In human trials, hesperidin or hesperidin-rich orange juice has improved endothelial function and postprandial microvascular reactivity, modestly lowered blood pressure in some studies — including a 159-person trial showing dose-dependent systolic and pulse-pressure reductions with sustained intake — and reduced…

Hesperidin Citrus Flavonoid

Hesperidin is a flavanone glycoside (a citrus bioflavonoid) found abundantly in oranges, lemons, and…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Does hesperidin 2S supplementation improve endothelial function in overweight individuals? [Plain-English summary of Am J Clin Nutr 2016, PMID 27797708, DOI 10.3945/ajcn.116.136960]. Magellan Longevity. https://magellanlongevity.com/study/s113.html
BibTeX
@misc{magellan_s113, title = {Does hesperidin 2S supplementation improve endothelial function in overweight individuals?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s113.html}}, note = {Plain-English summary of PubMed PMID 27797708; DOI 10.3945/ajcn.116.136960; Am J Clin Nutr 2016. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s113.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 27797708 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.